Physician profile
Page Barden
NPI 1932115102
$1,012.89
in general payments reported to CMS, 2019-2025
12 companies · $129 in 2025
The $129 reported for 2025 was more than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $56.96 · 2020: $10.88 · 2021: $158 · 2022: $160 · 2023: $431 · 2024: $66.05 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $413 · Food and Beverage: $164 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $412.74 |
| Food and Beverage | $163.89 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $654.77 | 2021-2024 | Opalescence |
| Straumann USA LLC | $70.18 | 2025 | |
| Zimvie INC. | $50.00 | 2024 | |
| Biohorizons Implant Systems INC. | $45.22 | 2021 | |
| Dentsply Sirona INC | $39.96 | 2025 | Astra Tech Implant System |
| Voco America INC. | $36.19 | 2019-2023 | Ionolux |
| Implant Direct Sybron International LLC | $32.81 | 2019 | |
| Kerr Corporation | $21.17 | 2022 | |
| Kulzer, LLC | $19.28 | 2025 | |
| Philips North America LLC | $15.76 | 2022 | |
| Orapharma, A Division of Bausch Health US, LLC | $14.10 | 2019 | |
| Nobel Biocare USA | $13.45 | 2023 | Nobelactive |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Page Barden listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.